At the beginning of the year, CombiGene entered into a collaboration agreement with the Danish company Zyneyro for the development of a treatment for severe temporary and chronic pain conditions. A new doctoral thesis at the University of Copenhagen now shows robust pain relief with the current drug candidates in experimental models.
Read more here: https://www.biostock.se/en/2023/02/combigenes-pain-project-receives-new-scientific-support/